Acadian Asset Management
NGNE icon

Acadian Asset Management’s Neurogene NGNE Stock Holding History

Acadian Asset Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-449
Closed -$18K – 1990
2024
Q3 		$18K Buy
+449
New +$17.4K ﹤0.01% 1991
2023
Q1 		– Sell
-1,059
Closed -$10K – 1888
2022
Q4 		$10K Hold
1,059
– – ﹤0.01% 1739
2022
Q3 		$13K Buy
+1,059
New +$21.6K ﹤0.01% 1626
2022
Q2 		– Sell
-385
Closed -$14K – 1804
2022
Q1 		$14K Sell
385
-785
-67% -$45.8K ﹤0.01% 1590
2021
Q4 		$112K Buy
+1,170
New +$143K ﹤0.01% 1353
2020
Q3 		– Sell
-802
Closed -$266K – 2295
2020
Q2 		$266K Sell
802
-13,080
-94% -$3.41M ﹤0.01% 1397
2020
Q1 		$3.16M Sell
13,882
-10,005
-42% -$2.06M 0.02% 480
2019
Q4 		$5.88M Sell
23,887
-6,596
-22% -$657K 0.03% 406
2019
Q3 		$1.74M Buy
30,483
+308
+1% +$18.8K 0.01% 725
2019
Q2 		$1.42M Hold
30,175
– – 0.01% 714
2019
Q1 		$1.63M Buy
30,175
+5,468
+22% +$276K 0.01% 740
2018
Q4 		$1.07M Buy
24,707
+5,497
+29% +$268K 0.01% 720
2018
Q3 		$1.13M Buy
+19,210
New +$1.13M ﹤0.01% 696
2018
Q2 		– Sell
-88
Closed -$25K – 1795
2018
Q1 		$25K Buy
+88
New +$24.3K ﹤0.01% 1465

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management's NGNE Position: Q4 2024 in Review

Acadian Asset Management sold out of Neurogene (NGNE) in Q4 2024, closing a stake of 449 shares — an estimated $18K sold.

Acadian Asset Management first reported a position in NGNE in Q1 2018 and held it in 14 quarters. The position peaked at $5.88M in Q4 2019. 88 funds tracked by Wall St. Rank hold NGNE as of Q4 2024.

  • Acadian Asset Management reported no remaining Neurogene position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 449 Neurogene shares in Q4 2024, an estimated $18K.
  • Acadian Asset Management first reported a position in Neurogene in Q1 2018 and held it in 14 quarters.
  • Acadian Asset Management's Neurogene position peaked at $5.88M in Q4 2019.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.